Отдых с малышом - дело ответственное и, увы, непредсказуемое. Что может потребоваться в поездке и какие средства стоит захватить с собой на всякий случай?

Swiss pharmaceutical giant Novartis has opened a non-profit research institute in northern Italy to develop vaccines for neglected diseases prevalent in the developing world. The new Novartis Vaccines Institute for Global Health is based in Siena, the home of Novartis Vaccines and Diagnostics. It will be managed independently of the commercial vaccine company and will have its own team, focusing initially on diarrhoeal diseases that have been overlooked by the major research funders. “Diarrhoeal diseases cause more deaths per year among children under five than malaria and AIDS together,” says Rino Rappuoli, global head of vaccine research at Novartis, who has been the force behind the venture. Rappuoli has spent his entire career in vaccine research, joining the Sclavo Institute in Siena 30 years ago, and seeing it through its takeover by Chiron in 1992 and then by Novartis two years ago. “I've had to develop vaccines for the rich world, where our customers are — but I knew how easily our technology and knowledge could be applied to vaccines for the poor world,” he says.